A Q&A on how device companies can respond to supply chain risks and regulations.
This month MedTech Intelligence will cover the diabetes market, along with technologies and solutions that are improving patient quality of life.
With an established base of medtech companies and a strong workforce, Ireland remains a key player in the global supply chain.
In order to keep innovation and manufacturing in the United States, device companies need federal and local support.
A peek at the latest miniaturization trends, including nano-robots that transport therapeutics to tumors.
Managing data, interoperability and cybersecurity issues were at the top of the list for industry stakeholders.
Mainstream media attention catapulted the company to the center of controversy for its finger-prick lab tests. Now FDA has taken issue with the company’s complaint handling and design validation.
Expect to see slow growth and more mergers & acquisitions.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.
There is a great unmet need for pediatric-specific devices. Why aren’t more manufacturers addressing this critical area?